Australian Pharmaceutical Industries Ltd (API.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 04-2005 | 04-2004 | 04-2003 | 04-2002 | 04-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,076 | 7,557 | 21,575 | 5,737 | 10,045 |
| Receivables | 428,797 | 389,866 | 347,562 | 296,883 | 253,252 |
| Inventories | 322,556 | 232,239 | 212,721 | 143,343 | 112,051 |
| Income taxes - deferred | 5,208 | N/A | 6,146 | N/A | N/A |
| Other current assets | 0 | 5,185 | 0 | 0 | 1,037 |
| TOTAL | $792,470 | $636,964 | $590,228 | $447,400 | $376,385 |
| Non-Current Assets | |||||
| PPE Net | 73,478 | 58,772 | 53,074 | 23,137 | 23,415 |
| Investments And Advances | 754 | 667 | 234 | N/A | 24,613 |
| Intangibles | 215,419 | 117,131 | 121,612 | 70,240 | 62,969 |
| Other Non-Current Assets | 32,969 | 9,071 | 7,633 | 116,564 | 54,894 |
| TOTAL | $322,620 | $185,641 | $182,553 | $209,941 | $165,891 |
| Total Assets | $1,115,090 | $822,605 | $772,781 | $657,341 | $542,276 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 69,185 | 71,019 | 11,760 | 98,565 | 50,578 |
| Accounts payable and accrued liabilities | 543,756 | 369,018 | 356,418 | 250,831 | 198,889 |
| TOTAL | $663,304 | $478,413 | $424,171 | $388,832 | $282,075 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,964 | 2,069 | 2,155 | N/A | N/A |
| Other Non-Current Liabilities | 4,665 | 2,674 | 3,256 | 1,889 | 2,246 |
| TOTAL | $8,172 | $5,784 | $5,424 | $2,107 | $2,901 |
| Total Liabilities | $671,476 | $484,197 | $429,595 | $390,939 | $284,976 |
| Shareholders' Equity | |||||
| Common Shares | 419,499 | 316,668 | 325,345 | 243,412 | 243,412 |
| Retained earnings | 19,137 | 20,610 | 16,509 | 22,473 | 13,371 |
| Other shareholders' equity | 4,978 | 1,130 | 1,332 | 517 | 517 |
| TOTAL | $443,614 | $338,408 | $343,186 | $266,402 | $257,300 |
| Total Liabilities And Equity | $1,115,090 | $822,605 | $772,781 | $657,341 | $542,276 |